Projects In Knowledge: Experts Responding to Your Questions: Video Q&A (Second Quarterly Activity)

Browse

Home »
Gastroenterology »
Hematology »
Infectious Diseases »
Neurology »
Oncology »
Osteoporosis »
Women's Health »

Keep up to date with us via twitter!

Latest News powered by:
Medical News

View RSS feed

Experts Responding to Your Questions: Video Q&A (Second Quarterly Activity)

Activity Goal | Learning Objectives | CME/CE Information | Disclosures | Technical Requirements

PLEASE NOTE:

As required by the ACCME, all participants must read the information below before proceeding to this activity.

After doing so, please click the Launch Activity button at the bottom of this page.

In this second installment of Experts Responding to Your Questions: Video Q&A, join Dr. Paul Miller as he responds to your questions about risk factors for fracture and using bone mineral density to diagnose osteoporosis.

Additional quarterly Q&A activities are also available —

Click Here to access the First Quarterly Q&A

Click Here to access the Third Quarterly Q&A

Click Here to access the Fourth Quarterly Q&A

For additional CME/CE activities in osteoporosis, please visit our Osteoporosis Compendium site, or our Education Initiative in Osteoporosis page.

Faculty
	Paul D. Miller, MD Distinguished Clinical Professor of Medicine University of Colorado Medical Center Colorado Center for Bone Research Lakewood, Colorado

top

Target Audience
This activity is designed for internists, primary care physicians, family practitioners, endocrinologists, gynecologists, orthopedic surgeons, rheumatologists, nurses, and other clinicians involved in the care of patients with or at risk of developing osteoporosis and fractures.

Activity Goal
The goal of this CME/CE activity is to address gaps in competence and practice performance in the management of osteoporosis through practical insights provided by experts to clinicians questions posed on a quarterly basis.
top

Learning Objective

Assess risk factors associated with the development of osteoporosis and fractures, as well as diagnostic methodology, to improve screening and diagnosis of osteoporosis/fractures in patients.

top

CME Information: Physicians
Statement of Accreditation
Projects In Knowledge^® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
Projects In Knowledge designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CE Information: Nurses
Projects In Knowledge^® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227.

This activity is approved for 0.25 nursing contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN, or PIK endorsement of any commercial product or service.

CE Information: Pharmacists

Projects In Knowledge^® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This interactive video q&a is worth up to 0.25 contact hour (0.025 CEU). The ACPE Universal Program Number assigned to this knowledge activity is 0052-0000-09-251-H01-P.
top

Disclosure Information
The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Paul D. Miller, MD, has received grant/research support from Amgen Inc, Eli Lilly and Company, Merck & Co, Inc, Novartis Pharmaceuticals Corporation, Procter & Gamble Pharmaceuticals, Roche Pharmaceuticals, and sanofi-aventis; and is a consultant for and/or on the advisory board of Amgen Inc, Eli Lilly and Company, GlaxoSmithKline, Merck & Co, Inc, Novartis Pharmaceuticals Corporation, NPS Pharmaceuticals Inc, Procter & Gamble Pharmaceuticals, Roche Pharmaceuticals, and sanofi-aventis.

Nancy J. Nordenson, MT (ASCP), MFA, has no significant relationships to disclose.

This activity will not include a discussion of unlabeled/unapproved uses of drugs or devices.

Projects In Knowledge’s staff members have no significant relationships to disclose.

top

Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

Contract for Mutual Responsibility in CME/CE

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

	Launch Activity Requires Flash 8 or higher and high-speed internet
top	1886.02

Program Information

Faculty

Learning Objectives

CME/CE Information

Disclosure Information

This activity is supported by an educational donation provided by Amgen.

Available for CME/CE:

Physicians
Release Date: December 22, 2009.
Termination Date: December 21, 2010.

Nurses
Release Date: December 22, 2009.
Termination Date: December 21, 2010.

Pharmacists
Release Date: December 22, 2009.
Termination Date: December 21, 2010.

Estimated time for completion of this activity:

CME:	15.00 minutes
CE:	15.00 minutes
CPE:	15.00 minutes

CME/CE Instructions:
To obtain CME/CE credit for this activity:

Watch the video Q&A carefully.
Achieve a passing score on the posttest.
Complete/submit the posttest and evaluation.
Instantly access and print out your certificate.
For Nurses: Please note that these activities are less than 30 minutes, and only when a minimum of thirty minutes of learning is obtained will your certificates of completion become valid. This means that you must complete at least 2 installments of the osteoporosis video Q&A activity to validate your certificates of completion.

There is no fee for this activity.